The increasing interest in potent weight management has led to considerable research into novel treatments. Currently, Retatrutide, a combined -action glucose-dependent insulinotropic polypeptide (GIP) and peptide receptor agonist , has shown positive results in medical trials, implying potential for significant weight reduction . As a result , man